0001689374-17-000002.txt : 20170303 0001689374-17-000002.hdr.sgml : 20170303 20170303152526 ACCESSION NUMBER: 0001689374-17-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170303 DATE AS OF CHANGE: 20170303 EFFECTIVENESS DATE: 20170303 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CTD HOLDINGS INC CENTRAL INDEX KEY: 0000922247 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 593029743 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-281775 FILM NUMBER: 17663210 BUSINESS ADDRESS: STREET 1: 14120 NW 126TH TERRACE CITY: ALACHUA STATE: FL ZIP: 32615-4816 BUSINESS PHONE: 386-418-8060 MAIL ADDRESS: STREET 1: 14120 NW 126TH TERRACE CITY: ALACHUA STATE: FL ZIP: 32615-4816 FORMER COMPANY: FORMER CONFORMED NAME: CYCLODEXTRIN TECHNOLOGIES DEVELOPMENT INC DATE OF NAME CHANGE: 19941012 D 1 primary_doc.xml X0707 D LIVE 0000922247 CTD HOLDINGS INC 6714 NW 16th Street, Suite B Gainesville FL FLORIDA 32563 386-418-8060 FLORIDA CYCLODEXTRIN TECHNOLOGIES DEVELOPMENT INC Corporation true Jeffrey L. Tate c/o CTD Holdings, Inc. 6714 NW 16th Street, Suite B Gainesville FL FLORIDA 32563 Executive Officer Director C.E. Rick Strattan c/o CTD Holdings, Inc. 6714 NW 16th Street, Suite B Gainesville FL FLORIDA 32563 Director Joseph (Judge) J. Farnan c/o CTD Holdings, Inc. 6714 NW 16th Street, Suite B Gainesville FL FLORIDA 32563 Director Francis Patrick Ostronic c/o CTD Holdings, Inc. 6714 NW 16th Street, Suite B Gainesville FL FLORIDA 32563 Director Nathan Scott Fine c/o CTD Holdings, Inc. 6714 NW 16th Street, Suite B Gainesville FL FLORIDA 32563 Executive Officer Director Markus W. Seiger c/o CTD Holdings, Inc. 6714 NW 16th Street, Suite B Gainesville FL FLORIDA 32563 Director William S. Shanahan c/o CTD Holdings, Inc. 6714 NW 16th Street, Suite B Gainesville FL FLORIDA 32563 Director George Fails c/o CTD Holdings, Inc. 6714 NW 16th Street, Suite B Gainesville FL FLORIDA 32563 Director Biotechnology Decline to Disclose 06b false 2017-02-23 false true true false 0 Scarsdale Equities LLC 134602 None None 10 Rockefeller Plaza New York NY NEW YORK 10020 CA CALIFORNIA CT CONNECTICUT DE DELAWARE FL FLORIDA MD MARYLAND MA MASSACHUSETTS NJ NEW JERSEY NY NEW YORK SC SOUTH CAROLINA false 2014191 2014191 0 false 37 153000 0 Fees paid to Scarsdale Equities LLC in an amount equal to $153,000 and they will be entitled to receive seven-year warrants to purchase 273,455 Units at an exercise price of $0.35 per share. 0 true false CTD HOLDINGS INC /s/ Jeffrey L. Tate Jeffrey L. Tate Chief Operating Officer 2017-03-03